Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001214659-24-019685)

Filing Details

Accession Number:: 0001214659-24-019685
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-11-27 16:24:09
Reporting Period:: 2024-11-26

Accepted Time:: 2024-11-27 16:24:09
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1398733	Aquestive Therapeutics Inc.	AQST	Pharmaceutical Preparations (2834)	208623253

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1960154	Cassie Jung	C/O Aquestive Therapeutics, Inc. 30 Technology Drive Warren NJ 07059	Chief Operating Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2024-11-26	44	$4.87	0	No	4	S	Indirect	by spouse IRA

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	by spouse IRA

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	2,000	Indirect	by spouse
Common Stock	233,066	Direct

Footnotes

Shares owned by spouse who shares Ms. Jung's household. Ms. Jung disclaims beneficial ownership of the shares held by her spouse, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16(a) of the Securities Exchange Act of 1940, as amended, or for any other purpose.